These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28495221)

  • 1. Impact of Provider Recommendation on Tdap Vaccination of Adolescents Aged 13-17 Years.
    Lu PJ; Yankey D; Jeyarajah J; O'Halloran A; Meyer SA; Elam-Evans LD; Reagan-Steiner S
    Am J Prev Med; 2017 Sep; 53(3):373-384. PubMed ID: 28495221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in Tdap Vaccination and Vaccine Information Needs Among Pregnant Women in the United States.
    Kriss JL; Albert AP; Carter VM; Jiles AJ; Liang JL; Mullen J; Rodriguez L; Howards PP; Orenstein WA; Omer SB; Fisher A
    Matern Child Health J; 2019 Feb; 23(2):201-211. PubMed ID: 30288661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetanus, diphtheria, and acellular pertussis vaccination among women of childbearing age-United States, 2013.
    O'Halloran AC; Lu PJ; Williams WW; Ding H; Meyer SA
    Am J Infect Control; 2016 Jul; 44(7):786-93. PubMed ID: 27372388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.
    Kretsinger K; Broder KR; Cortese MM; Joyce MP; Ortega-Sanchez I; Lee GM; Tiwari T; Cohn AC; Slade BA; Iskander JK; Mijalski CM; Brown KH; Murphy TV; ; ;
    MMWR Recomm Rep; 2006 Dec; 55(RR-17):1-37. PubMed ID: 17167397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.
    Talbird SE; Graham J; Mauskopf J; Masseria C; Krishnarajah G
    J Manag Care Spec Pharm; 2015 Jan; 21(1):88-99, 99a-c. PubMed ID: 25562776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetanus, diphtheria, pertussis vaccination coverage before, during, and after pregnancy - 16 States and New York City, 2011.
    Ahluwalia IB; Ding H; D'Angelo D; Shealy KH; Singleton JA; Liang J; Rosenberg KD;
    MMWR Morb Mortal Wkly Rep; 2015 May; 64(19):522-6. PubMed ID: 25996094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waning Tdap Effectiveness in Adolescents.
    Klein NP; Bartlett J; Fireman B; Baxter R
    Pediatrics; 2016 Mar; 137(3):e20153326. PubMed ID: 26908667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kentucky's improvement in administering Tdap for adolescents: The National Immunization Survey-Teen 2008-2012.
    Myers J
    Ky Nurse; 2014; 62(4):8. PubMed ID: 25362756
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
    MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with tetanus, diphtheria, and acellular pertussis vaccine of pregnant women enrolled in Medicaid--Michigan, 2011-2013.
    Housey M; Zhang F; Miller C; Lyon-Callo S; McFadden J; Garcia E; Potter R;
    MMWR Morb Mortal Wkly Rep; 2014 Sep; 63(38):839-42. PubMed ID: 25254561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescent Vaccination Performance in South Carolina Compared to the United States.
    Roberts JR; Naifeh M; Jacobson RM; Hinton E; O'Brien E; Rogacki B; Thompson D; Margolis B; Darden PM
    J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):117-21. PubMed ID: 27141702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tdap vaccination coverage during pregnancy, active component service women, 2006-2014.
    Eick-Cost AA; Hu Z
    MSMR; 2015 May; 22(5):11-4. PubMed ID: 25996172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
    McCormack PL
    Drugs; 2012 Sep; 72(13):1765-91. PubMed ID: 22931522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal Conjugate and Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccination Among HIV-infected Youth.
    Setse RW; Siberry GK; Moss WJ; Wheeling J; Bohannon BA; Dominguez KL;
    Pediatr Infect Dis J; 2016 May; 35(5):e152-7. PubMed ID: 26855409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.
    Thierry-Carstensen B; Jordan K; Uhlving HH; Dalby T; Sørensen C; Jensen AM; Heilmann C
    Vaccine; 2012 Aug; 30(37):5464-71. PubMed ID: 22776216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
    Brandon D; Kimmel M; Kuriyakose SO; Kostanyan L; Mesaros N
    Vaccine; 2018 Oct; 36(42):6325-6333. PubMed ID: 30197282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of tetanus, diphtheria, acellular pertussis and influenza vaccination during pregnancy among full-term deliveries in a medically underserved population.
    Doraivelu K; Boulet SL; Biswas HH; Adams JC; Haddad LB; Jamieson DJ
    Vaccine; 2019 Sep; 37(41):6054-6059. PubMed ID: 31471152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Low Uptake of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Immunization in Privately Insured Women in the United States.
    Butler AM; Layton JB; Li D; Hudgens MG; Boggess KA; McGrath LJ; Weber DJ; Becker-Dreps S
    Obstet Gynecol; 2017 Apr; 129(4):629-637. PubMed ID: 28277354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.